Researcher Database

Yoshida Kiryu

FacultyNephrology
PositionAssistant Professor
Last Updated :2026/01/28

Researcher

基本情報

Profile and Settings

  • 氏名

    Yoshida Kiryu

Affiliation

  • Nephrology, Assistant Professor

Location

  • Northern Yokohama Hospital

Achievements

Published Papers

  • Renin-angiotensin system inhibitor use and cardio-renal outcomes in non-proteinuric chronic kidney disease: a post-hoc analysis of the Frontier of Renal Outcome Modification-Japan study, Hirohito Sugawara, Kiryu Yoshida, Chie Saito, Yoshinori Saito, Masanori Kato, Akihiko Kato, Ichiei Narita, Shoichi Maruyama, Jun Wada, Takashi Wada, Masahiro Yamamoto, Hidetoshi Ito, Kunihiro Yamagata, Hiroaki Ogata, Hypertension Research, Apr. 2026, Peer-reviewed
  • Evaluation of a deep learning-based automated detection algorithm for identifying COVID-19 pneumonia on chest X-ray images, SEKIMOTO Atsuhito;MIZUKAMI Takuya;MURAKAMI Kouzou;TANAKA Akihiko;TARUMI Yoko;YOSHIDA Kiryu;MAKITA Maya;TOYOFUKU Kosuke;KATO Masako;ITO Yoshinori;OHGIYA Yoshimitsu;SAGARA Hironori;UCHIDA Naoki, Showa Med Univ J, 37(4):196 - 202, Dec. 2025, Peer-reviewed, DOI:https://doi.org/10.15369/smuj.37.4_196
  • Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis-A post hoc analysis of the LANDMARK study., Kiryu Yoshida; Takuya Mizukami; Masafumi Fukagawa; Tadao Akizawa; Hokuto Morohoshi; Takehiko Sambe; Akiko Takeshima; Hidetoshi Ito; Hiroaki Ogata; Naoki Uchida, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 27(3):523 - 529, Jun. 2023, Peer-reviewed, DOI:10.1111/1744-9987.13954
  • Target phosphate and calcium levels in patients undergoing hemodialysis: a post-hoc analysis of the LANDMARK study., Yoshida Kiryu;Mizukami Takuya;Fukagawa Masafumi;Akizawa Tadao;Morohoshi Hokuto;Sambe Takehiko;Ito Hidetoshi;Ogata Hiroaki;Uchida Naoki; , Clinical and experimental nephrology, 27(2), Oct. 2022, Peer-reviewed, DOI:10.1007/s10157-022-02288-9

Presentations

  • 血液透析(HD)患者における活性化ビタミンD製剤(VDRA)使用と心血管イベント(CVE)の関連ーLANDMARK研究より, 吉田輝龍,水上拓也,諸星北人,伊藤英利,内田直樹,緒方浩顕, 第65回 日本腎臓学会学術総会, 12 Jun. 2022, 兵庫


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.